Detalhe da pesquisa
1.
In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31843997
2.
In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31843999
3.
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.
Clin Infect Dis
; 68(5): 865-872, 2019 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30202941
4.
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
Clin Infect Dis
; 68(10): 1691-1698, 2019 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30321315
5.
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1.
Clin Infect Dis
; 66(8): 1222-1229, 2018 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29281036
6.
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.
Antimicrob Agents Chemother
; 62(4)2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29358292
7.
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study).
Antimicrob Agents Chemother
; 62(5)2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29530858
8.
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.
JAMA
; 320(12): 1249-1258, 2018 09 25.
Artigo
Inglês
| MEDLINE | ID: mdl-30264119
9.
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 64(suppl_1): S24-S29, 2017 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28350900
10.
Single-dose oritavancin in the treatment of acute bacterial skin infections.
N Engl J Med
; 370(23): 2180-90, 2014 Jun 05.
Artigo
Inglês
| MEDLINE | ID: mdl-24897083
11.
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.
Clin Trials
; 13(1): 22-30, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26768569
12.
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus.
Clin Infect Dis
; 60(5): 787-96, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25472944
13.
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
Clin Infect Dis
; 60(2): 254-62, 2015 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25294250
14.
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Clin Infect Dis
; 61 Suppl 2: S87-93, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26316562
15.
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.
Clin Infect Dis
; 60(5): 741-9, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25389255
16.
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Antimicrob Agents Chemother
; 59(10): 6170-4, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26248356
17.
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Antimicrob Agents Chemother
; 59(2): 864-71, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25421472
18.
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.
BMC Infect Dis
; 15: 503, 2015 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26547411
19.
Methicillin-resistant Staphylococcus aureus: an evolving pathogen.
Clin Infect Dis
; 58 Suppl 1: S10-9, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24343827
20.
Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
Clin Infect Dis
; 68(Suppl 3): S191-S192, 2019 04 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30957163